FV-100

DRUG3 trials

Sponsors

Bristol-Myers Squibb, ContraVir Pharmaceuticals, Inc.

Conditions

Acute Herpes ZosterHerpes ZosterPostherpetic NeuralgiaShingles

Phase 1

A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers

CompletedNCT02322957

ContraVir Pharmaceuticals, Inc.Acute Herpes Zoster

Start: 2015-02-28End: 2015-07-31Target: 24Updated: 2015-10-01

Phase 2

A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster

CompletedNCT00900783

Bristol-Myers SquibbHerpes Zoster, Shingles

Start: 2009-05-31End: 2010-12-31Updated: 2015-10-12

Phase 3

A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

TerminatedNCT02412917

ContraVir Pharmaceuticals, Inc.Herpes Zoster, Postherpetic Neuralgia, Shingles

Start: 2015-06-30End: 2017-11-30Updated: 2017-12-22